Lexeo Therapeutics, Inc. - Common Stock (NQ:LXEO)

3.180 -0.130 (-3.93%)

Delayed Quote Updated: 3:49 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lexeo Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >

Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results ↗

July 15, 2024

Via Benzinga

Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 15, 2024

Via Benzinga

Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet ↗

July 15, 2024

Via Benzinga

Why Top 4% Biotech Stock Lexeo Therapeutics Just Gave Up A Breakout ↗

July 15, 2024

The company is in the early stages of testing a gene therapy for the heart complications of a genetic disease.

Via Investor's Business Daily

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July ↗

July 15, 2024

Via Benzinga

Topics Stocks

Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights

May 09, 2024

From Lexeo Therapeutics

Via GlobeNewswire

Lexeo Therapeutics to Participate in Upcoming Investor Conferences

May 07, 2024

From Lexeo Therapeutics

Via GlobeNewswire

Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday ↗

April 22, 2024

Via Benzinga

Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

April 22, 2024

From Lexeo Therapeutics

Via GlobeNewswire

Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy

April 16, 2024

From Lexeo Therapeutics

Via GlobeNewswire

Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing

March 13, 2024

Lexeo extends runway into 2027 with private placement co-led by Braidwell LP and Adage Capital Partners LP with participation from new and existing investors including RA Capital Management, Surveyor...

From Lexeo Therapeutics

Via GlobeNewswire

RBC Capital Maintains Outperform Rating for Lexeo Therapeutics: Here's What You Need To Know ↗

March 12, 2024

Via Benzinga

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

March 11, 2024

From Lexeo Therapeutics

Via GlobeNewswire

Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing

March 11, 2024

Lexeo extends runway into 2027 with private placement co-led by Braidwell LP and Adage Capital Partners LP, with participation from new and existing investors including RA Capital Management, Surveyor...

From Lexeo Therapeutics

Via GlobeNewswire

Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday ↗

March 06, 2024

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.

Via Benzinga

Topics Stocks

Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments

February 05, 2024

From Lexeo Therapeutics

Via GlobeNewswire

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 18, 2024

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the...

Via Benzinga

Fastenal Posts Upbeat Earnings, Joins NovoCure, Taiwan Semiconductor Manufacturing And Other Big Stocks Moving Higher On Thursday ↗

January 18, 2024

U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Thursday. Shares of Fastenal Company (NASDAQ: FAST) rose during Thursday’s session after the company reported...

Via Benzinga

Topics Stocks

Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From LEXEO Therapeutics

Via GlobeNewswire

Marathon Digital, Canaan, CleanSpark And Other Big Stocks Moving Lower On Tuesday ↗

December 26, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 40 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)

December 18, 2023

From LEXEO Therapeutics

Via GlobeNewswire

LXEO Stock Earnings: Lexeo Therapeutics Reported Results for Q3 2023 ↗

December 11, 2023

Lexeo Therapeutics just reported results for the third quarter of 2023.

Via InvestorPlace

Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights

December 11, 2023

From LEXEO Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 01, 2023

Via Benzinga

Pineapple Financial Drops In Trading Debut ↗

November 05, 2023

Shares of Pineapple Financial slipped over 25% in their trading debut following a downsized IPO. The tech-focused mortgage brokerage had cut the size of its offering from 1.25 million to 875,000 common...

Via Talk Markets

Topics Initial Public Offering

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.